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abstract: Paediatric hypercalcaemia is a rare condition which can be easily overlooked or misdiagnosed. We report 
two paediatric patients who presented to the Department of Paediatrics, Pardubice Hospital, Pardubice, Czech Republic, 
in 2009 and 2010, respectively. Each patient was diagnosed with hypercalcaemia due to a different cause. The first 
case involved a seven-month-old infant who presented with failure to thrive, vomiting and psychomotor retardation. 
Fluorescent in situ hybridisation revealed Williams-Beuren syndrome. The second patient was a 16-year-old 
girl with abdominal pain and renal colic due to hypercalcaemia-induced urolithiasis. High parathyroid hormone serum 
levels suggested primary hyperparathyroidism. An adenoma of the left upper parathyroid gland was diagnosed 
via technetium-99m-labelled methoxyisobutyl isonitrile single photon emission computed tomography and removed 
surgically. Hypercalcaemia should be considered in the differential diagnosis of various disease states, particularly 
among infants who fail to thrive or children with abdominal pain.
Keywords: Hypercalcemia; Williams-Beuren Syndrome; Hyperparathyroidism; Parathyroid Adenoma; Case Report; 
Czech Republic.
امللخ�ص: يعد فرط الكال�شيوم يف دماء الأطفال حالة نادرة، ميكن اأن ُتغفل اأو ُيغلط يف ت�شخي�شها. ونعر�ص هنا حلالتي طفلني مري�شني 
ِجيَء بهما لق�شم الأطفال يف م�شت�شفى باردوب�ص بجمهورية الت�شيك يف عامي 2009 و 2010، على التوايل. ومت ت�شخي�ص كل من احلالتني 
على اأنهما فرط كال�شيوم الدم ل�شببني خمتلفني. وكانت احلالة الأوىل لر�شيع عمره �شبعة اأ�شهر توقف منوه، وكان م�شابا بقيء وتخلف 
حركي نف�شي. وثبت من التهجني الفلوري املو�شعي اأن هذا املري�ص م�شاب مبتالزمة ويليام-بيورين. اأما احلالة الثانية فكانت لفتاة يف 
ال�شاد�ص ع�رس من عمرها م�شابة باأمل بطني ومغ�ص كلوي نتيجة حت�شي احلالب الذي �شببه فرط كال�شيوم الدم. وُوجد لدى هذه املري�شة 
اأي�شا ارتفاع يف تركيز هرمون الدريقات يف م�شل الدم. واكت�شف عن طريق الت�شوير املقطعي بالنبعاث الفوتوين املنفرد وجود ورم غدي 
يف اجلزء ال�شمايل الأعلى من الدريقة، ومتت اإزالته جراحيا. ينبغي اأن يو�شع احتمال وجود فرط الكال�شيوم يف الت�شخي�ص التفريقي بني 
خمتلف الأمرا�ص، خا�شة عند الر�شع الذين توقف منوهم، اأو امل�شابني باأمل يف البطن.
الكلمات املفتاحية: فرط كال�شيوم الدم؛ مبتالزمة ويليام-بيورين؛ ارتفاع تركيز هرمون الدريقات؛ ورم الدريقات الغدي؛ تقرير حالة؛ جمهورية الت�شيك.
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Hypercalcaemia is defined as serumcalcium (S-Ca) levels of >2.7 mmol/L, with S-Ca levels of >3.0 mmol/L requiring thera-
peutic intervention and those of >3.5 mmol/L consid-
ered life-threatening and requiring immediate action.1–4 
Treatment consists of ensuring adequate hydration and 
administering glucocorticoids, diuretics (i.e. furosemide) 
and bisphosphonates (e.g. pamidronate or zoledronate). 
Vitamin D and calcium supplementation should be 
avoided, as well as exposure to sunshine.1–3 
Hypercalcaemia in childhood is rare and may have 
different origins, including vitamin D intoxication, hyper- 
parathyroidism, hyperthyroidism, granulomatous disease, 
Williams-Beuren syndrome, calcium-sensing receptor 
mutations, Jansen’s metaphyseal chondrodysplasia, hypo- 
phosphatasia, subcutaneous fat necrosis and humoral or 
osteolytic malignancy.1–3 A complete evaluation of blood 
minerals together with assessments of serum alkaline 
phosphatase (S-ALP) activity and parathyroid hormone 
(S-PTH) levels usually helps to ensure the correct diagn- 
osis. This case report describes two cases of paediatric 
hypercalcaemia arising from different causes, one case 
in an infant and the other in an adolescent girl.
Case One
A seven-month-old girl was referred to the Department 
of Paediatrics, Pardubice Hospital, Pardubice, Czech 
Republic, in 2009 due to lethargy, psychomotor retard- 
ation, muscle hypotonia, anorexia, vomiting, constipation 
and failure to thrive. Her family and perinatal history was 
normal, with a 41-week gestational period, birthweight 
of 3,670 g, birth length of 50 cm and Apgar scores of 
6–9. Up until the age of five months, her rate of weekly 
weight gain had been normal at 150–200 g; however, 
between months five and six, she gained only 100 g (from 
7,200 g to 7,300 g) and between months six and seven, 
she lost 460 g (from 7,300 g to 6,840 g). She was being 
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S-Ca levels (from 3.54 to 3.02 mmol/L and 2.4 mmol/L, 
respectively) within 48 hours. One week after admission, 
the patient was discharged with a bodyweight of 7,300 g. 
She continued receiving a low-calcium milk-free diet 
(≤200 mg of calcium/day), primarily consisting of 
vegetable soup, poultry, mixed fruit and pastries, with no 
vitamin D supplementation. Her S-Ca levels remained 
between 2.25–2.6 mmol/L; however, after an isolated 
attempt to reintroduce milk at the age of eight months, 
her S-Ca levels increased transiently to 3.5 mmol/L 
[Figure 1A]. 
Despite the normalisation in her S-Ca levels, the 
patient’s psychomotor development remained slow 
and the muscle hypotonia persisted. Furthermore, her 
weight gain rate remained inappropriately low. She had 
no apparent dysmorphic facial features. Accordingly, 
at the age of 11 months, the patient underwent 
fluorescent in situ hybridisation (FISH) which revealed 
a chromosome 7q11.23 deletion indicative of Williams-
Beuren syndrome. This was confirmed when ‘elfin’ facial 
features became apparent at the age of one year (i.e. a 
broad forehead, stellate iris pattern, flat nasal bridge, 
full cheeks and lips, long smooth philtrum and wide 
mouth). In the following years, she displayed behaviour 
characteristic of Williams-Beuren syndrome (i.e. over 
friendliness, empathy, generalised anxiety, specific phobias 
and attention deficit disorder).5–8 From the age of 
10 months, her blood S-Ca levels rem-ained normal. 
At the time of writing, the patient was nine years 
old and under close surveillance. Although mildly 
to moderately developmentally delayed, her anthro-
pometric data were within normal reference ranges 
for the syndrome.8
Case Two
A 16-year old girl was admitted to the Department of 
Paediatrics, Pardubice Hospital, in 2010 with complaints 
of recurrent abdominal pain. Her family and personal 
breastfed, administered infant formula and vegetable 
soup and was receiving regular antirachitic prophylaxis 
(oral cholecalciferol at 500 IU/day). Upon admission, 
blood biochemistry tests revealed high levels of S-Ca 
(3.8 mmol/L), low levels of S-ALP (1.5 µkat/L), mildly 
elevated serum creatinine levels (52 µmol/L) and low 
S-PTH levels (4.8 ng/L). Other biochemistry results 
were normal [Table 1].
Echocardiography revealed very mild pulmonary 
artery stenosis (gradient of 10–15 mmHg) and nephro- 
calcinosis was apparent on a renal ultrasound. However, 
a wrist X-ray was normal, without any osteolytic signs. 
The combination of hypercalcaemia, normophosphat-
aemia and low S-PTH and S-ALP levels ruled out primary 
hyperparathyroidism (HPT); additionally, vitamin D intox- 
ication was excluded by the low-to-normal 25-hydroxy- 
vitamin D levels. Accordingly, idiopathic infantile hyper- 
calcaemia was suspected and, on the second day 
of admission, the patient received an intravenous 
infusion of 0.9% sodium chloride with 5% dextrose 
together with methylprednisolone and furosemide 
(2 mg/kg/day each). This resulted in a gradual decrease in 
Table 1: Blood biochemistry results of case one
Serum levels Result Normal range*
Calcium in mmol/L 3.8 2.2–2.6
Sodium in mmol/L 134 135–145
Potassium in mmol/L 3.7 3.5–5.0
Phosphorus in mmol/L 1.13 1.1–2.2
Magnesium in mmol/L 0.7 0.6–1.1
ALP in µkat/L 1.5 2.2–9.3
Creatinine in µmol/L 52 20–40
PTH in ng/L 4.8 15–65
25-OH vitamin D in nmol/L 72 75–125
ALP = alkaline phosphatase; PTH = parathyroid hormone; OH = hydroxy.
*Age-specific reference range.
 
Figure 1: Serum calcium changes over time for (A) case one and (B) case two. The dotted lines represent the upper and 
lower reference values. 
S-Ca = serum calcium.
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Histological evaluation confirmed the diagnosis of an 
adenoma. Subsequently, her S-PTH levels dropped to 
15 ng/L and thereafter remained between 10–20 ng/L. 
The postoperative course was uneventful over the next 
three days; however, on the fourth day, the patient 
developed hungry bone syndrome with a drop in S-Ca 
levels (1.9 mmol/L) [Figure 1B]. Accordingly, she 
received calcium (3,000 mg/day) and cholecalciferol 
(5,000–7,500 IU/day) supplementation for four months. 
At the time of writing, the patient was 24 years old, in 
a good state of health with normal S-Ca levels and was 
being monitored by an endocrinologist.
Discussion
Hypercalcaemia should be considered in infants and 
children with failure to thrive, constipation, hypotonia 
and psychomotor retardation. In the current case report, 
the two presented cases of paediatric hypercalcaemia 
serve as an important clinical reminder of the complex 
differential diagnosis of mineral metabolism disorders. 
In the first patient, the underlying cause of hypercal-
caemia was Williams-Beuren syndrome, while the second 
was caused by primary HPT due to an adenoma of the 
parathyroid gland.
Williams-Beuren syndrome is caused by a 7q11.23 
contiguous gene deletion of the Williams-Beuren synd-
rome critical region that encompasses the elastin gene.5 
It is transmitted in an autosomal dominant manner and 
occurs in one in 10,000 live births, of which most cases 
are de novo. Hypercalcaemia occurs in 15–50% of affected 
children, although the specific causative mechanism by 
which this occurs is currently unknown.5 Apart from 
hypercalcaemia, typical manifestations include congenital 
heart defects (especially supravalvular aortic and periph- 
eral pulmonary artery stenosis), hypercalciuria with 
nephrocalcinosis/urolithiasis, endocrine abnormalities 
(i.e. thyroid hypoplasia, impaired glucose tolerance and 
growth hormone deficiency), feeding problems, failure 
to thrive, hypertension, dental anomalies and distinctive 
facial features and behavioural characteristics, such as 
irritability, anxiety, overfriendliness and hypersensit-
ivity to noise.6–8 However, not all of these are present 
among affected infants, with certain manifestations only 
becoming apparent later, usually in early childhood.6 
While the prognosis is generally good, there is an incr- 
eased risk of cardiovascular morbidities and patients 
require periodic monitoring by specialists (i.e. an endocr- 
inologist, cardiologist, neurologist, psychologist, psychi-
atrist, stomatologist and orthopaedic surgeon).5,8
Generally, primary HPT is rare in children and 
adolescents, constituting less than 5% of all cases.9–12 At 
the Johns Hopkins Children’s Center in Baltimore, Mary- 
land, USA, only 16 paediatric and adolescent patients 
history was normal. One week prior, a urinalysis had 
revealed proteinuria and microscopic haematuria and 
she had been provisionally diagnosed with a urinary tract 
infection and prescribed painkillers and amoxicillin/cla- 
vulanate by a general practitioner. This resulted in temp- 
orary cessation of the pain. However, the abdominal pain 
and microscopic haematuria recurred and she was admit- 
ted to hospital. Upon admission, her blood pressure was 
normal (120/80 mmHg) and an abdominal X-ray and 
ultrasound examination failed to show any concrements, 
although dilation of the left renal pelvis and ureter was 
apparent. Laboratory results revealed high S-Ca levels 
of 3.2 mmol/L, normal phosphorus levels of 0.9 mmol/L 
(normal age-specific range: 0.7–1.5 mmol/L), normal S- 
ALP levels of 1.5 µkat/L (normal age-specific range: 
0.7–2.5 µkat/L) and high S-PTH levels of 126.0 ng/L 
(normal age-specific range: 15.0–65.0 ng/L). A helical 
computed tomography (CT) scan revealed a 3-mm 
urolithiasis which was voided spontaneously.
Multiple endocrine neoplasia (MEN) types I and 
II and a jaw tumour were ruled out as the patient’s thy- 
rotropin and free thyroxin levels were normal, along 
with magnetic resonance imaging (MRI) of the brain, 
skull and abdomen. A diagnosis of primary HPT was 
established. As a technetium-99m (99Tc)-labelled metho- 
xyisobutyl isonitrile (MIBI) scan showed only mild accum- 
ulation at the upper left parathyroid gland, 99Tc-MIBI 
single photon emission CT (SPECT) was performed; this 
confirmed left upper parathyroid enlargement, most 
probably due to an adenoma. This was also corroborated 
by MRI and a neck ultrasound. As measured by dual 
X-ray absorptiometry, her bone mineral density was 
within normal limits for her age. She was prescribed 
20 mg/day of furosemide and her S-Ca levels dropped 
below 3 mmol/L within one week.
Two months later, the patient underwent a parathy- 
roidectomy of the left upper parathyroid gland [Figure 2]. 
 
Figure 2: Gross photograph of a parathyroid adenoma 
excised from a 16-year-old girl with recurrent abdominal 
pain and hypercalcaemia.
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with primary HPT (mean age: 16.3 ± 2.9 years) were 
reported between 1984 and 2001.9 In another study 
from Belgrade, Serbia, there were seven paediatric cases 
(mean age: 15.7 years) out of 522 patients with primary 
HPT seen between 2004 and 2010.10 Libánský et al. 
analysed 10 primary HPT patients between 10–17 years 
old between 1996 and 2007.11 Currently, the diagnosis 
of primary HPT in children and adolescents is mostly 
incidental.11,12 The most frequent manifestation of paed- 
iatric primary HPT is urolithiasis in 64% of cases, with 
other symptoms including limb pain, fractures, hyper-
tension, fatigue and constipation.1,9–12 
In the current case report, the second patient 
presented with renal colic and hypercalcaemia due to 
a single parathyroid adenoma. Among children, prim-
ary HPT is mostly due to a parathyroid adenoma; how- 
ever, it can also occur within the context of other syndr- 
omes, such as parathyroid hyperplasia in MEN types I 
and II and HPT with jaw tumours.9–12 While a 99Tc-MIBI 
scan, neck ultrasound and MRI scan can help to 
localise a parathyroid adenoma, 99Tc-MIBI SPECT is 
the most reliable method in this regard.13,14 In cases 
of paediatric parathyroid adenomas, surgical removal 
is the only effective treatment for primary HPT.11,15 
However, hungry bone syndrome is a frequent post-
operative complication and usually lasts for 3–4 months, 
with the duration reflecting the time span of bone 
remodelling.16,17
Conclusion
Hypercalcaemia should be considered in the differential 
diagnosis for various disease states, especially among 
infants with psychomotor retardation and failure to 
thrive and children with abdominal pain, renal colic and 
urolithiasis.
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